NMC:TSXVNuvau Minerals Inc. Analysis
Data as of 2026-03-12 - not real-time
$10.68
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The fund is trading at $10.68, just below the 20‑day SMA (10.76) but above the 50‑day (10.64) and 200‑day (10.58) averages, indicating a modest bullish bias despite a bearish MACD histogram. Volume is increasing and the 30‑day volatility is moderate at 8.1%, while the computed beta of 0.23 suggests the price moves far less than the broader market. The dividend yield remains attractive at 7.68%, yet the trailing PE of 534 versus an industry average of 16 signals severe earnings compression, and the high debt‑to‑equity ratio (≈75) raises concerns about financial resilience.
The discounted cash‑flow model values the fund around $12.45, implying a discount to current pricing, but the low ROE (0.18%) and modest free cash flow highlight limited growth upside. Overall, the technical setup is cautiously bullish, but fundamental stressors—especially earnings weakness and leverage—temper enthusiasm.
The discounted cash‑flow model values the fund around $12.45, implying a discount to current pricing, but the low ROE (0.18%) and modest free cash flow highlight limited growth upside. Overall, the technical setup is cautiously bullish, but fundamental stressors—especially earnings weakness and leverage—temper enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above the $10.5 support level
- Increasing volume supporting the bullish trend direction
- Bearish MACD histogram suggests short‑term downside risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value ($12.45) indicates upside potential
- High dividend yield (7.68%) provides income cushion
- Low market beta reduces exposure to broader equity swings
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 19% and strong operating margins
- Book value per share ($10.92) close to market price, suggesting intrinsic value
- Potential for dividend stability if earnings improve
Key Metrics & Analysis
Financial Health
Revenue Growth19.00%
Profit Margin1.81%
P/E Ratio534.0
ROE0.18%
ROA2.96%
Debt/Equity74.75
P/B Ratio1.0
Op. Cash Flow$49.6M
Free Cash Flow$37.5M
Industry P/E16.4
Technical Analysis
TrendBullish
RSI47.1
Support$10.50
Resistance$10.93
MA 20$10.76
MA 50$10.64
MA 200$10.59
MACDBearish
VolumeIncreasing
Fear & Greed Index74.52
Valuation
Fair Value$12.45
GradeUndervalued
TypeValue
Dividend Yield7.68%
Risk Assessment
Beta0.23
Volatility8.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.